Myovant Sciences Announces Positive Results from Second Phase 3

MYOV: Myovant Sciences, Inc.
2020-06-23 07:30:10
Myovant Sciences Announces Positive Results from Second Phase 3 Study Evaluating Once-Daily Relugolix Combination Therapy in Women with Endometriosis